Dendreon Annual Meeting notes - WOW! | DNDNQ Message Board Posts


Dendreon Corporation

  DNDNQ website

DNDNQ   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  283007 of 488166  at  6/10/2009 6:25:24 PM  by

mj121983


 In response to msg 283003 by  tetrimbath
view thread

Re: Dendreon Annual Meeting notes - WOW!

Now that was a thorough job, thank you very much! You painted a very clear picture and I felt like I was there with everyone. 
 
"Provenge's initial label will cover approximately 100,000 patients annually. He showed the 9901 and 9902B data. (I was surprised to see curves on the 9902B data eventually collapse, and I am sure someone on the board can explain that.) "
 
The curves eventually collapse because Provenge does not provide immortal life! Eventually, everyone (both placebo and those on Provenge) will die, either due to PC, or due to other causes. 
 
Thanks again! 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 21  
   Views: 643 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
283015 Re: Dendreon Annual Meeting notes - WOW! bobrmd 11 6/10/2009 7:51:28 PM




Financial Market Data provided by
.
Loading...